BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 836921)

  • 1. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze.
    Howard JL; Grant LD; Breese GR
    J Comp Physiol Psychol; 1974 Jun; 86(6):995-1007. PubMed ID: 4836849
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of d-amphetamine sulfate given to pregnant mice on activity and on catecholamines in the brains of offspring.
    Middaugh LD; Blackwell LA; Santos CA; Zemp JW
    Dev Psychobiol; 1974 Sep; 7(5):429-38. PubMed ID: 4426470
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 7. Short- and long-term effects of intraventricular 6-hydroxydopamine in rats pretreated with a monoamine oxidase inhibitor.
    Vetulani J; Reichenberg K; Wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1977; 29(6):645-56. PubMed ID: 564059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
    Stricker EM; Zigmond MJ
    J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 11. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
    Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ
    Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional brain catecholamine levels after intraventricular 6-hydroxydopamine in the neonatal rat.
    Pappas BA; Saari M; Peters AV
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):751-4. PubMed ID: 959671
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of renal hypertensive rats.
    Kubo T; Hashimoto M; Ohashi T
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):270-8. PubMed ID: 708153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactivity in developing rats: sex differences in 6-hydroxydopamine and amphetamine effects.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1981 Jan; 14(1):5-10. PubMed ID: 7193330
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amphetamine on electroshock responses in developing rats.
    Vernadakis A; Robb D
    Dev Psychobiol; 1974 Jan; 7(1):89-95. PubMed ID: 4812273
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase activity in brain regions after intraventricular 6-hydroxydopamine in the neonatal rat.
    Peters DA; Pappas BA; Taub H; Saari M
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):161-4. PubMed ID: 28554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.